Literature DB >> 12480132

Development of the alpha7 nicotinic cholinergic receptor in rat hippocampal formation.

Catherine E Adams1, Ron S Broide, Yiling Chen, Ursula H Winzer-Serhan, Theodore A Henderson, Frances M Leslie, Robert Freedman.   

Abstract

The alpha7 nicotinic receptor has been implicated in the regulation of a variety of developmental processes. The goal of the present study was to assess whether the alpha7 receptor might participate in the regulation of hippocampal ontogeny by describing the spatiotemporal development of alpha7 mRNA and alpha-bungarotoxin binding in rat hippocampal formation. Message for the alpha7 receptor was initially observed in the hippocampal neuroepithelium at embryonic day 13 and in the anlage of the hippocampal formation on embryonic day 14. Binding of alpha-bungarotoxin was initially seen on embryonic day 15 in the dorsal portion of the anlage of stratum oriens and stratum radiatum-lacunosum moleculare, but was never observed in the neuroepithelium. Dramatic elevations in both alpha7 mRNA and alpha-bungarotoxin binding were observed in most regions of the hippocampal formation neonatally. The levels of both alpha7 message and protein gradually decreased during the first three postnatal weeks to adult levels in most regions. The lack of alpha-bungarotoxin binding in the neuroepithelium suggests that the alpha7 receptor does not influence neurogenesis. The early appearance and complex, prolonged pattern of development of the alpha7 receptor suggest that it may influence processes as diverse as cell migration, dendritic elaboration and apoptosis during hippocampal maturation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12480132     DOI: 10.1016/s0165-3806(02)00547-3

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  48 in total

1.  Glutamatergic synapse formation is promoted by α7-containing nicotinic acetylcholine receptors.

Authors:  Adrian F Lozada; Xulong Wang; Natalia V Gounko; Kerri A Massey; Jingjing Duan; Zhaoping Liu; Darwin K Berg
Journal:  J Neurosci       Date:  2012-05-30       Impact factor: 6.167

Review 2.  Is being plastic fantastic? Mechanisms of altered plasticity after developmental traumatic brain injury.

Authors:  Christopher C Giza; Mayumi L Prins
Journal:  Dev Neurosci       Date:  2006       Impact factor: 2.984

3.  Postnatal expression of alpha2 nicotinic acetylcholine receptor subunit mRNA in developing cortex and hippocampus.

Authors:  Jong-Hyun Son; Ursula H Winzer-Serhan
Journal:  J Chem Neuroanat       Date:  2006-10-12       Impact factor: 3.052

4.  Reduced Chrna7 expression in mice is associated with decreases in hippocampal markers of inhibitory function: implications for neuropsychiatric diseases.

Authors:  C E Adams; J C Yonchek; K M Schulz; S L Graw; J Stitzel; P U Teschke; K E Stevens
Journal:  Neuroscience       Date:  2012-01-25       Impact factor: 3.590

5.  Reversible inhibition of GABAA receptors by alpha7-containing nicotinic receptors on the vertebrate postsynaptic neurons.

Authors:  Jingming Zhang; Darwin K Berg
Journal:  J Physiol       Date:  2007-01-04       Impact factor: 5.182

6.  Presynaptic α7 nicotinic acetylcholine receptors enhance hippocampal mossy fiber glutamatergic transmission via PKA activation.

Authors:  Qing Cheng; Jerrel L Yakel
Journal:  J Neurosci       Date:  2014-01-01       Impact factor: 6.167

7.  Early postnatal nicotine exposure disrupts the α2* nicotinic acetylcholine receptor-mediated control of oriens-lacunosum moleculare cells during adolescence in rats.

Authors:  Kang Chen; Sakura Nakauchi; Hailing Su; Saki Tanimoto; Katumi Sumikawa
Journal:  Neuropharmacology       Date:  2015-09-16       Impact factor: 5.250

8.  The development of nicotinic receptors in the human medulla oblongata: inter-relationship with the serotonergic system.

Authors:  Jhodie R Duncan; David S Paterson; Hannah C Kinney
Journal:  Auton Neurosci       Date:  2008-11-05       Impact factor: 3.145

9.  alpha7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues.

Authors:  C A Briggs; M R Schrimpf; D J Anderson; E J Gubbins; J H Grønlien; M Håkerud; H Ween; K Thorin-Hagene; J Malysz; J Li; W H Bunnelle; M Gopalakrishnan; M D Meyer
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

10.  Perinatal Phosphatidylcholine Supplementation and Early Childhood Behavior Problems: Evidence for CHRNA7 Moderation.

Authors:  Randal G Ross; Sharon K Hunter; M Camille Hoffman; Lizbeth McCarthy; Betsey M Chambers; Amanda J Law; Sherry Leonard; Gary O Zerbe; Robert Freedman
Journal:  Am J Psychiatry       Date:  2015-12-07       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.